Clinical Trial Update: Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating guadecitabine in combination with carboplatin for extensive-stage small cell lung cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Guadecitabine (guadecitabine)

Snippet

Sponsor: Shadia Jalal, MD | Conditions: Small Cell Lung Cancer, Extensive-stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-12-20